Thursday's Top 10 Articles, Videos

NEW YORK ( TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.

4 Banks Running at High Efficiency
Philip van Doorn
These four bank and thrift holding companies had the best third-quarter efficiency ratios among actively traded names. (Featured stocks: WFSL, ORIT, SBNY, HCBK)

10 Top S&P 500 Stocks for 2012
Scott Rothbort
As we head into a fresh new year with a clean slate, here are 10 top S&P 500 stocks for 2012, one from each sector. (Featured stocks: WPI, BTU, LNC, KFT)

5 Sexy iPhone Apps for 2012
Chris Ciaccia
Here are five new, sexy iPhone apps for 2012 to help make your iPhone experience more enjoyable.

Biotech Buyside Predictions for 2012
Adam Feuerstein
Gilead Sciences is loved, Amgen is hated and new drug launches will continue to struggle, say Wall Street's biotech investing pros.

Bank of America's Gaping $32B Mortgage Hole Makes It a Citi 'Buy'
Dan Freed
Analyst Keith Horowitz cuts his price target but reiterates his 'buy' rating.

AMR Shares Have Gone Away
Ted Reed
AMR now trades over the counter under the symbol AAMRQ.

General Electric Gets Overweight Nod by Morgan Stanley (Update 1)
Dan Freed
Veteran analyst Nigel Coe restarts industrials coverage for Morgan Stanley.

Analysts' Actions: GE, GOOG, HON, DOV, ED
RealMoney Staff
Here are today's top research calls.

5 Stocks That Will Have Investors Going Nuclear
Frank Byrt
Electric utilities that rely on nuclear-power generation are poised for fast growth.

Dendreon: Provenge Q4 Sales Beat
Adam Feuerstein
Dendreon surprises with better-than-expected sales of its prostate cancer therapy Provenge in the December quarter.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...

Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...

Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions

Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions

Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes

Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes